UPEXI, INC.
For the period ended Jun 30, 2026. Filed Sep 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Sep 17, 2026
UPXI$0.62-6.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ (Deficit) Equity
| Preferred Stock | Preferred Stock | Common Stock | Common Stock | Additional Paid | Accumulated | TotalStockholders' | |
|---|---|---|---|---|---|---|---|
| Shares* | Par* ** | Shares* | Par * ** | In Capital | Deficit | Equity | |
| Balance, June 30, 2024 | 25,000 | $1 | 1,045,429 | $11 | $53,375,502 | $(46,859,613) | $6,515,901 |
| Stock-based compensation | - | - | - | - | 2,106,862 | - | 2,106,862 |
| Issuance of preferred series A stock | 125,000 | 1 | - | - | 324,999 | - | 325,000 |
| Issuance of stock for the conversion of debt | - | - | 742,896 | 7 | 1,749,993 | - | 1,750,000 |
| Capitalized interest related to convertible debt | - | - | - | - | 27,891 | - | 27,891 |
| Issuance of stock for the exercise of warrant on convertible debt | - | - | 83,334 | 1 | 249,999 | - | 250,000 |
| Issuance of stock for the cashless exercise of options | - | - | 7,278 | - | - | - | - |
| Issuance of stock for vested restricted stock grants | - | - | 102,583 | 1 | (1) | - | - |
| Issuance of stock for services | - | - | 19,577 | 1 | 249,999 | - | 250,000 |
| Issuance of stock for the exercise of cashless warrants | - | - | 299,091 | 3 | (3) | - | - |
| Issuance of common stock | - | - | 35,970,383 | 359 | 92,555,694 | - | 92,556,053 |
| Net loss | - | - | - | - | - | (13,684,209) | (13,684,209) |
| Balance, June 30, 2025 | 150,000 | $2 | 38,270,571 | $383 | $150,640,935 | $(60,543,822) | $90,097,498 |
| Stock-based compensation | - | - | - | - | 21,895,814 | - | 21,895,814 |
| Issuance of stock for the exercise of warrants | - | - | 8,600,952 | 86 | 107,803 | - | 107,889 |
| Issuance of vested stock from equity incentive plans | - | - | 533,665 | 5 | (5) | - | - |
| Issuance of common stock, net of issuance costs | - | - | 28,665,219 | 287 | 70,638,129 | - | 70,638,416 |
| Issuance of stock for conversion of debt | - | - | 5,526,238 | 55 | 12,285,067 | - | 12,285,122 |
| Common stock repurchases | - | - | (2,894,287) | (29) | (2,773,930) | - | (2,773,959) |
| Net loss | - | - | - | - | - | (246,064,698) | (246,064,698) |
| Balance, June 30, 2026 | 150,000 | $2 | 78,702,358 | $787 | $252,793,813 | $(306,608,520) | $(53,813,918) |
- Common stock has been restated to reflect the 1 for 20 reverse split
** Common stock par value has been adjusted to $0.00001
UPEXI, INC.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.